LONDON – Laboratoris Sanifit SL has closed Spain's largest ever private biotech round, raising €72.2 million (US$80.9 million) to fund phase III development of SNF-472 in the treatment of calciphylaxis, an orphan disease that occurs in end-stage renal disease patients on dialysis.